Dietary Derived Propionate Regulates Pathogenic Fibroblast Function and Ameliorates Experimental Arthritis and Inflammatory Tissue Priming

Nutrients. 2021 May 13;13(5):1643. doi: 10.3390/nu13051643.

Abstract

Short-chain fatty acids are gut-bacteria-derived metabolites that execute important regulatory functions on adaptive immune responses, yet their influence on inflammation driven by innate immunity remains understudied. Here, we show that propionate treatment in drinking water or upon local application into the joint reduced experimental arthritis and lowered inflammatory tissue priming mediated by synovial fibroblasts. On a cellular level, incubation of synovial fibroblasts with propionate or a physiological mixture of short-chain fatty acids interfered with production of inflammatory mediators and migration and induced immune-regulatory fibroblast senescence. Our study suggests that propionate mediates its alleviating effect on arthritis by direct abrogation of local arthritogenic fibroblast function.

Keywords: arthritis; cellular senescence; diet; inflammatory tissue priming; propionate; synovial fibroblasts.

MeSH terms

  • Aging / drug effects
  • Animals
  • Arthritis, Experimental / drug therapy*
  • Arthritis, Experimental / pathology
  • Female
  • Fibroblasts / drug effects*
  • Inflammation / drug therapy*
  • Inflammation / pathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Propionates / therapeutic use*
  • Real-Time Polymerase Chain Reaction
  • Synovial Fluid / cytology

Substances

  • Propionates